Cancer of the Testis

The book covers the complete field of testis cancer including the germ cell tumors and the stromal tumors, from epidemiology to new chemotherapeutic agents and schedules, throughout genetic features, risk factors, risk adapted treatments, role of different types of surgery and special clinical situations. Special attention is focused on fertility issues, late effects of the primary therapy and the economical aspects of the different treatment policies.

As a result of the third Consensus Conference, a consensual follow-up can be devised and a chapter dedicated to this controversial and not yet defined matter.

This book is the state-of-the-art reference text on testis cancer and is an essential resource for all urologists, medical oncologists and radio-oncologists.

Cancer of the Testis presents a thorough account of every aspect of this disease, including histology, risk factors, prognosis, clinical presentation, diagnosis and treatment. Additionally, there is a focus on the pertinent issues of fertility, late effects of primary therapy, follow-up after primary treatment and testicular cancer in childhood.

With an international authorship comprised of many of the key contributors to the field, this book brings together a rich and balanced range of perspectives.

A state-of-the-art reference volume on testicular cancer, this book is essential reading for urologists, medical oncologists and radio-oncologists.

M. Pilar Laguna, MD PhD, is an Associate Professor in Urology at the University of Amsterdam, The Netherlands.

Peter Albers, MD, is Chairman of the Department of Urology at Dusseldorf University, Germany.

Carsten Bokemeyer, MD, is Director of Oncology and Hematology at Hubertus Wald Tumorzentrum at the University Medical Center in Hamburg, Germany.

Jerome P. Richie, MD, is the Elliot C. Cutler Professor of Urologic Surgery at Harvard Medical School and Chief of Urology at Brigham and Women’s Hospital in Boston, USA.